ARKK
ARK Innovation ETF·CBOE
--
--(--)
--
--(--)
Key Stats
Assets Under Management
6.25BUSD
Fund Flows (1Y)
-1.97BUSD
Dividend Yield
--
Discount/Premium to NAV
0.05%
Shares Outstanding
89.10M
Expense Ratio
0.75%
About ARK Innovation ETF
Issuer
ARK
Brand
ARK
Home Page
Inception Date
Oct 31, 2014
Structure
Open-Ended Fund
Index Tracked
--
Management Style
Active
Dividend Treatment
Distributes
Distribution Tax Treatment
Qualified dividends
Income Tax Type
Capital Gains
Max ST Capital Gains Rate
39.60%
Max LT Capital Gains Rate
20.00%
Primary Advisor
ARK Investment Management LLC
Distributor
Foreside Fund Services LLC
ARKK is full of cutting-edge firms, selected to represent the advisers highest-conviction investment ideas in this space. The adviser defines disruptive innovation as a technologically enabled new product or service that has the potential to change the way the world works. ARKK's portfolio focuses on companies involved in genomics, automation, transportation, energy, artificial intelligence and materials, shared technology, infrastructure and services , and technologies that make financial services more efficient . ARKK's proprietary macroeconomic and fundamental research, aimed at assessing company potential,drives security selection and weighting. ARKK's research integrates ESG considerations as a secondary assessment.
Classification
Asset Class
Equity
Category
Sector
Focus
Theme
Niche
Broad Thematic
Strategy
Active
Geography
U.S.
Weighting Scheme
Proprietary
Selection Criteria
Proprietary
Analysis
Sector
Healthcare
28.35%
Technology
25.09%
Consumer Cyclical
15.26%
Financial Services
13.58%
Communication Services
11.46%
Industrials
6.26%
Healthcare
28.35%
Technology
25.09%
Consumer Cyclical
15.26%
Financial Services
13.58%
Communication Services
11.46%
Industrials
6.26%
Asset
Holdings
Symbol
Ratio
TSLA
Tesla
11.30%
CRSP
CRISPR Therapeutics
5.66%
TEM
Tempus AI
5.33%
ROKU
Roku
5.04%
SHOP
Shopify
4.10%
AMD
Advanced Micro Devices
3.89%
Symbol
Ratio
COIN
Coinbase Global
3.70%
HOOD
Robinhood Markets
3.65%
BEAM
Beam Therapeutics
3.56%
TWST
Twist Bioscience
3.33%
Top 10 Weight 49.56%
10 Total Holdings
See all holdings
Related Funds
Seasonals
Volume Profile
Trade Flow Insight
Community Forum
Loading...
Related News
No articles available
You can ask Aime
No Data
